Kristi Heim | 08 Jul 2010 | Seattle Times
The Institute for OneWorld Health, a San Francisco-based nonprofit, said it has received $10.7 million from the Gates Foundation to begin commercial production of a key ingredient for malaria treatment.
Joe De Capua | 06 Jul 2010 | Voice of America
Health officials in Cambodia have found a strain of malaria that's showing resistance to the main anti-malaria drug, known as artemisinin. Resistance means patients can take longer to recover.
None | 06 Jul 2010 | IRIN News
More than half the paediatric fevers treated in public health clinics in Africa are caused by diseases other than malaria, according to a study by Oxford University and other research groups, whose authors caution against the "continued indiscriminate use of anti-malarials for all fevers across Africa."
Gasirigwa Sengiyumva | 05 Jul 2010 | Tanzania Daily News
The issue of substandard and counterfeit medicines remain a huge problem, not only to sub- Saharan Africa as a whole but also to this country in particular. This is an appalling situation that proves fatal for some of the world's poorest, most vulnerable people.
Talea Miller | 24 Jun 2010 | PBS NewsHour
Fake drugs manufactured to resemble dozens of well-known pharmaceutical brands are making their way across international borders and threatening lives, the World Customs Organization said Thursday.
Ifedayo Adebayo | 16 Jun 2010 | NEXT
The World Health Organisation, governments, and non-profit groups are not paying enough attention to the dangers of drug-resistant drugs, a report from the Centre for Global Development has warned.
John Irish | 10 Jun 2010 | Reuters
Counterfeit drugs have become a $200-billion-a-year industry and the 176-nation World Customs Organization (WCO) will sign a declaration later this month to fight the scourge, an official said on Thursday. Fake or substandard versions of medicines are often hidden in cargoes sent on circuitous routes to mask their country of origin.
Nick Schulz | 03 Jun 2010 | livemint.com
By many important measures, the Indian pharmaceutical industry is thriving. Indian firms are increasingly seen as innovators, losing their earlier global reputation as copycat firms happy to free ride on Western medical advances.
James Ratemo | 05 May 2010 | The Standard (Kenya)
Malaria has been in the category of Aids and tuberculosis — as killer diseases — and deserves deathblow at whatever cost. However, studies show the fight against the killer disease has been jeorpadised not by lack of enough drugs, but poor distribution.
Godwin Akor | 29 Apr 2010 | Daily Champion (Lagos)
National Agency for Food and Drug Administration and Control (NAFDAC) has discovered the sale of some fake malaria drugs in Gboko Benue State and its environs.